In a report released yesterday, Kristen Kluska from Cantor Fitzgerald maintained a Buy rating on Celldex (CLDX – Research Report), with a ...
Celldex Therapeutics has halted work on its solid-tumor-focused bispecific as the biotech prioritizes its work in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback